Paris, France

Michel Polak

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michel Polak: Innovator in Diabetes Treatment

Introduction

Michel Polak is a prominent inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of diabetes and related conditions. With a total of 3 patents, his work focuses on innovative pharmaceutical compositions and methods that aim to improve the health of premature infants and enhance pancreatic endocrine cell mass.

Latest Patents

One of his latest patents involves KATP antagonists, specifically glibenglamid, which are used for promoting growth and treating hyperglycaemia in premature infants. This invention relates to pharmaceutical compositions that include an ATP-sensitive potassium (K ATP) channel antagonist, such as sulfonylureas and meglitinides. The methods outlined in this patent aim to treat hyperglycaemia and promote growth in infants who are premature or small for their gestational age.

Another significant patent by Polak discloses a method for increasing the pool of Ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass. This invention describes a technique for enhancing the pool of Ngn3+ endocrine progenitor cells derived from stem cells by using a SUR1/Kir6.2 channel inhibitor. Additionally, it presents a method for increasing the mass of pancreatic endocrine cells, particularly β cells, and offers a new approach to treating diabetes.

Career Highlights

Throughout his career, Michel Polak has worked with notable institutions, including Assistance Publique-Hôpitaux de Paris and Université Paris Descartes. His research and innovations have had a profound impact on the medical community, particularly in the areas of endocrinology and neonatal care.

Collaborations

One of his key collaborators is Paul Czernichow, with whom he has worked on various projects aimed at advancing medical treatments and understanding of diabetes.

Conclusion

Michel Polak's contributions to the field of medicine through his patents and research have paved the way for new treatments in diabetes and neonatal care. His innovative approaches continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…